133 related articles for article (PubMed ID: 6187403)
1. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart.
Birdsall NJ; Burgen AS; Hulme EC; Stockton JM; Zigmond MJ
Br J Pharmacol; 1983 Feb; 78(2):257-9. PubMed ID: 6187403
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
5. Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Beleslin DB; Nedelkovski V
Neuropharmacology; 1988 Sep; 27(9):949-56. PubMed ID: 2460797
[TBL] [Abstract][Full Text] [Related]
6. Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation.
Velazquez-Moctezuma J; Gillin JC; Shiromani PJ
Brain Res; 1989 Nov; 503(1):128-31. PubMed ID: 2482113
[TBL] [Abstract][Full Text] [Related]
7. The interaction of McN-A-343 with pirenzepine and other selective muscarine receptor antagonists at a prejunctional muscarine receptor.
Choo LK; Mitchelson F; Vong YM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):430-8. PubMed ID: 2581148
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.
Kromer W; Baron E; Beinborn M; Boer R; Eltze M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):165-70. PubMed ID: 1692974
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of muscarinic receptors involved in McN-A-343-induced effects on intestinal motility and heart rate in conscious dogs.
Schiavone A; Sagrada A; Micheletti R; Giachetti A
Br J Pharmacol; 1988 Jun; 94(2):566-72. PubMed ID: 2456119
[TBL] [Abstract][Full Text] [Related]
10. M2 muscarinic receptor agonists produce hypotension and bradycardia when injected into the nucleus tractus solitarii.
Sundaram K; Murugaian J; Watson M; Sapru H
Brain Res; 1989 Jan; 477(1-2):358-62. PubMed ID: 2467726
[TBL] [Abstract][Full Text] [Related]
11. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
12. Dimethylsulfonium analogues of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl)carbamoyl]oxy]-2-butynyl] dimethylsulfonium perchlorates.
Mellin C; Vargas HM; Ringdahl B
J Med Chem; 1989 Jul; 32(7):1590-3. PubMed ID: 2472484
[TBL] [Abstract][Full Text] [Related]
13. Modulation by the muscarinic agonist McN-A-343 of noradrenaline release from vascular sympathetic neurones.
Nedergaard OA
J Cardiovasc Pharmacol; 1980; 2(5):629-43. PubMed ID: 6157955
[No Abstract] [Full Text] [Related]
14. Effect of tilting on the pressor responses to McN-A-343, a muscarinic sympathetic ganglion stimulant.
Fielden R; Sutton TJ; Taylor EM
Br J Pharmacol; 1980; 71(1):287-95. PubMed ID: 6162496
[TBL] [Abstract][Full Text] [Related]
15. Modulation by the muscarinic agonist McN-A-343 of release of noradrenaline from sympathetic neurones in the rabbit pulmonary artery [proceedings].
Nedergaard OA
Br J Pharmacol; 1980 Jan; 68(1):136P. PubMed ID: 6153542
[No Abstract] [Full Text] [Related]
16. A comparative study of the effects induced by MCN-A-343 and acetylcholine on the isolated toad rectus abdominis.
Simioni LR; Corrado AP; Jurkiewicz A
Gen Pharmacol; 1976 Aug; 7(2-3):127-32. PubMed ID: 61902
[TBL] [Abstract][Full Text] [Related]
17. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
18. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic antidepressant drugs as antagonists of muscarinic receptors in sympathetic ganglia.
Weinstock M; Cohen D
Eur J Pharmacol; 1976 Dec; 40(2):321-8. PubMed ID: 62672
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of the muscarinic agonist McN-A-343 on vascular neuroeffector transmission.
Nedergaard OA
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):354-65. PubMed ID: 6179387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
